Constipation Caused by Anti-calcitonin Gene-Related Peptide Migraine Therapeutics Explained by Antagonism of Calcitonin Gene-Related Peptide’s Motor-Stimulating and Prosecretory Function in the Intestine
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Constipation Caused by Anti-calcitonin Gene-Related Peptide Migraine Therapeutics Explained by Antagonism of Calcitonin Gene-Related Peptide’s Motor-Stimulating and Prosecretory Function in the Intestine
Authors
Keywords
-
Journal
Frontiers in Physiology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-01-11
DOI
10.3389/fphys.2021.820006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Migraine therapeutics differentially modulate the CGRP pathway
- (2021) Minoti Bhakta et al. CEPHALALGIA
- Real‐world efficacy, tolerability, and safety of ubrogepant
- (2021) Chia‐Chun Chiang et al. HEADACHE
- Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial
- (2021) David Kudrow et al. BMC Neurology
- Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene‒related peptide‐targeted monoclonal antibody migraine preventives in participants with migraine: A randomized phase 1b drug–drug interaction study
- (2021) Abhijeet Jakate et al. HEADACHE
- The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study
- (2021) Marta Torres-Ferrús et al. JOURNAL OF NEUROLOGY
- Real-Life Response to Erenumab in a Therapy-Resistant Case Series of Migraine Patients From the Province of Québec, Eastern Canada
- (2021) Marzieh Eghtesadi et al. CLINICAL DRUG INVESTIGATION
- Treatment with the monoclonal calcitonin gene‐related peptide receptor antibody erenumab: A real‐life study
- (2021) Simone de Vries Lentsch et al. EUROPEAN JOURNAL OF NEUROLOGY
- Safety and tolerability evaluation of erenumab for the preventive treatment of migraine
- (2021) Christina I. Deligianni et al. Expert Opinion On Drug Safety
- Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial in Japanese and Korean patients
- (2021) Fumihiko Sakai et al. HEADACHE
- Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack
- (2021) Paul K. Winner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Calcitonin Gene‐Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information
- (2021) Abubker Omaer et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention
- (2021) Robert Belvís et al. JOURNAL OF HEADACHE AND PAIN
- CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience
- (2021) Armin Scheffler et al. JOURNAL OF HEADACHE AND PAIN
- Efficacy and safety of erenumab in Japanese migraine patients with prior preventive treatment failure or concomitant preventive treatment: subgroup analyses of a phase 3, randomized trial
- (2021) Koichi Hirata et al. JOURNAL OF HEADACHE AND PAIN
- Atogepant for the Preventive Treatment of Migraine
- (2021) Jessica Ailani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness and Safety of CGRP-mAbs in Menstrual-Related Migraine: A Real-World Experience
- (2021) Marcello Silvestro et al. Pain and Therapy
- Diarrhea-Predominant and Constipation-Predominant Irritable Bowel Syndrome: Current Prescription Drug Treatment Options
- (2021) Emily V. Wechsler et al. DRUGS
- Chronic Idiopathic Constipation in Adults: A Review on Current Guidelines and Emerging Treatment Options
- (2021) Gabrio Bassotti et al. Clinical and Experimental Gastroenterology
- Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)
- (2020) Messoud Ashina et al. CEPHALALGIA
- Long‐Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52‐Week Extension Trial
- (2020) Jessica Ailani et al. HEADACHE
- Intrinsic sensory neurons provide direct input to motor neurons and interneurons in mouse distal colon via varicose baskets
- (2020) David J. Smolilo et al. JOURNAL OF COMPARATIVE NEUROLOGY
- No central action of CGRP antagonising drugs in the GTN mouse model of migraine
- (2020) Sarah L Christensen et al. CEPHALALGIA
- Two‐Hour CGRP Infusion Causes Gastrointestinal Hyperactivity: Possible Relevance for CGRP Antibody Treatment
- (2020) Katrine Falkenberg et al. HEADACHE
- Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy
- (2020) Raffaele Ornello et al. JOURNAL OF HEADACHE AND PAIN
- Understanding side-effects of anti-CGRP and anti-CGRP receptor antibodies
- (2020) Kristian Agmund Haanes et al. JOURNAL OF HEADACHE AND PAIN
- Efficacy and safety of eptinezumab in patients with chronic migraine
- (2020) Richard B. Lipton et al. NEUROLOGY
- Efficacy, tolerability, and safety of erenumab for the preventive treatment of persistent post-traumatic headache attributed to mild traumatic brain injury: an open-label study
- (2020) Håkan Ashina et al. JOURNAL OF HEADACHE AND PAIN
- Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience
- (2020) Antonio Russo et al. JOURNAL OF HEADACHE AND PAIN
- A prospective real-world analysis of erenumab in refractory chronic migraine
- (2020) Giorgio Lambru et al. JOURNAL OF HEADACHE AND PAIN
- Erenumab in highly therapy-refractory migraine patients: First German real-world evidence
- (2020) Armin Scheffler et al. JOURNAL OF HEADACHE AND PAIN
- One-year sustained efficacy of erenumab in episodic migraine
- (2020) Peter J. Goadsby et al. NEUROLOGY
- Real-world effectiveness and tolerability of erenumab: A retrospective cohort study
- (2020) Saad Kanaan et al. CEPHALALGIA
- Safety and Tolerability of 3 CGRP Monoclonal Antibodies in Practice: A Retrospective Cohort Study
- (2020) Ashley Alex et al. HEADACHE
- Real‐World Patient Experience With Erenumab for the Preventive Treatment of Migraine
- (2020) Jennifer Robblee et al. HEADACHE
- Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy–2) study
- (2020) Stephen Silberstein et al. JOURNAL OF HEADACHE AND PAIN
- Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial
- (2020) Wim M Mulleners et al. LANCET NEUROLOGY
- Pharmacokinetics, Pharmacodynamics and Drug–Drug Interactions of New Anti-Migraine Drugs—Lasmiditan, Gepants, and Calcitonin-Gene-Related Peptide (CGRP) Receptor Monoclonal Antibodies
- (2020) Danuta Szkutnik-Fiedler Pharmaceutics
- Peripheral and central nervous system distribution of the CGRP neutralizing antibody [125I] galcanezumab in male rats
- (2019) Kirk W Johnson et al. CEPHALALGIA
- Calcitonin Gene‐Related Peptide Modulators – The History and Renaissance of a New Migraine Drug Class
- (2019) Richard Hargreaves et al. HEADACHE
- Erenumab Side Effects
- (2019) Lawrence Robbins HEADACHE
- Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial
- (2019) Robert Croop et al. LANCET
- Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine
- (2019) Richard B. Lipton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial
- (2019) Michel D Ferrari et al. LANCET
- Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine
- (2019) Richard B. Lipton et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier
- (2019) Rodrigo Noseda et al. CEPHALALGIA
- Leukocyte Apheresis Using a Fiber Filter Suppresses Colonic Injury Through Calcitonin Gene–Related Peptide Induction
- (2019) Hiroshi Yamasaki et al. INFLAMMATORY BOWEL DISEASES
- Ubrogepant for the Treatment of Migraine
- (2019) David W. Dodick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synaptic activation of putative sensory neurons by hexamethonium-sensitive nerve pathways in mouse colon
- (2018) Timothy J. Hibberd et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
- (2018) Vladimir Skljarevski et al. CEPHALALGIA
- ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
- (2018) David W Dodick et al. CEPHALALGIA
- Current understanding of trigeminal ganglion structure and function in headache
- (2018) Karl Messlinger et al. CEPHALALGIA
- Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine
- (2018) David W. Dodick et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy
- (2018) Bianca Raffaelli et al. Neurotherapeutics
- Evaluation of Galcanezumab for the Prevention of Episodic Migraine
- (2018) Virginia L. Stauffer et al. JAMA Neurology
- A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
- (2018) Angelo Camporeale et al. BMC Neurology
- Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study
- (2018) Uwe Reuter et al. LANCET
- Galcanezumab in chronic migraine
- (2018) Holland C. Detke et al. NEUROLOGY
- Pathophysiology and management of opioid-induced constipation: European expert consensus statement
- (2018) Adam D Farmer et al. United European Gastroenterology Journal
- RAMP1 suppresses mucosal injury from dextran sodium sulfate-induced colitis in mice
- (2017) Noriko Kawashima-Takeda et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Blocking CGRP in migraine patients – a review of pros and cons
- (2017) Marie Deen et al. JOURNAL OF HEADACHE AND PAIN
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- Mucosal glucagon-like peptide 1 (GLP-1) responses are mediated by calcitonin gene-related peptide (CGRP) in the mouse colon and both peptide responses are area-specific
- (2017) I.R. Tough et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Anti-CGRP antibodies block CGRP-induced diarrhea in mice
- (2017) Eric A. Kaiser et al. NEUROPEPTIDES
- Fremanezumab for the Preventive Treatment of Chronic Migraine
- (2017) Stephen D. Silberstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Controlled Trial of Erenumab for Episodic Migraine
- (2017) Peter J. Goadsby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission
- (2017) Rebecca E. Yarwood et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bowel Disorders
- (2016) Brian E. Lacy et al. GASTROENTEROLOGY
- Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2016) Hong Sun et al. LANCET NEUROLOGY
- Sensory innervation of the guinea pig colon and rectum compared using retrograde tracing and immunohistochemistry
- (2016) B. N. Chen et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Wiping Out CGRP: Potential Cardiovascular Risks
- (2016) Antoinette MaassenVanDenBrink et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The novel CGRP receptor antagonist BIBN4096BS alleviates a postoperative intestinal inflammation and prevents postoperative ileus
- (2015) T. R. Glowka et al. NEUROGASTROENTEROLOGY AND MOTILITY
- TRPM8 on mucosal sensory nerves regulates colitogenic responses by innate immune cells via CGRP
- (2014) P R de Jong et al. Mucosal Immunology
- Calcitonin Gene-Related Peptide: Physiology and Pathophysiology
- (2014) F. A. Russell et al. PHYSIOLOGICAL REVIEWS
- The Receptor TGR5 Mediates the Prokinetic Actions of Intestinal Bile Acids and Is Required for Normal Defecation in Mice
- (2012) Farzad Alemi et al. GASTROENTEROLOGY
- Localization of calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein 1 (RAMP1) in human gastrointestinal tract
- (2012) Graeme S. Cottrell et al. PEPTIDES
- Local injection of dsRNA targeting calcitonin receptor-like receptor (CLR) ameliorates Clostridium difficile toxin A-induced ileitis
- (2012) A. Bhargava et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Suppression of ovalbumin-induced allergic diarrhea by diminished intestinal peristalsis in RAMP1-deficient mice
- (2011) Rintaro Yoshikawa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- TRPA1 and Substance P Mediate Colitis in Mice
- (2011) Matthias A. Engel et al. GASTROENTEROLOGY
- Immunohistochemical analysis of substance P-containing neurons in rat small intestine
- (2010) Retsu Mitsui CELL AND TISSUE RESEARCH
- Characterisation of calcitonin gene-related peptide-immunoreactive neurons in the myenteric plexus of rat colon
- (2009) Retsu Mitsui CELL AND TISSUE RESEARCH
- Identification of neuron types in the submucosal ganglia of the mouse ileum
- (2009) Caterina Mongardi Fantaguzzi et al. CELL AND TISSUE RESEARCH
- Involvement of afferent neurons in the pathogenesis of endotoxin-induced ileus in mice: Role of CGRP and TRPV1 receptors
- (2009) Benedicte Y. De Winter et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Neurochemical and morphological phenotypes of vagal afferent neurons innervating the adult mouse jejunum
- (2009) l. l. tan et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Standardized concept for the treatment of gastrointestinal dysmotility in critically ill patients—Current status and future options
- (2008) Michael K. Herbert et al. CLINICAL NUTRITION
- Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
- (2008) Tony W Ho et al. LANCET
- Distinct chemical classes of medium-sized transient receptor potential channel vanilloid 1-immunoreactive dorsal root ganglion neurons innervate the adult mouse jejunum and colon
- (2008) L.L. Tan et al. NEUROSCIENCE
- Roles of Calcitonin Gene–Related Peptide in Maintenance of Gastric Mucosal Integrity and in Enhancement of Ulcer Healing and Angiogenesis
- (2007) Takashi Ohno et al. GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More